AlphaQuest LLC Buys 3,458 Shares of Sotera Health Company $SHC

AlphaQuest LLC raised its stake in Sotera Health Company (NASDAQ:SHC) by 7.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 49,590 shares of the company’s stock after acquiring an additional 3,458 shares during the period. AlphaQuest LLC’s holdings in Sotera Health were worth $551,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Farther Finance Advisors LLC grew its position in shares of Sotera Health by 55.9% in the 2nd quarter. Farther Finance Advisors LLC now owns 9,861 shares of the company’s stock valued at $110,000 after buying an additional 3,534 shares during the last quarter. Teacher Retirement System of Texas bought a new stake in shares of Sotera Health during the 1st quarter valued at about $266,000. Strs Ohio bought a new stake in shares of Sotera Health during the 1st quarter valued at about $1,003,000. Public Employees Retirement System of Ohio boosted its position in shares of Sotera Health by 4.0% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 48,635 shares of the company’s stock valued at $541,000 after purchasing an additional 1,891 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its position in shares of Sotera Health by 0.3% during the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company’s stock valued at $4,109,000 after purchasing an additional 1,037 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Barclays upped their target price on Sotera Health from $17.00 to $19.00 and gave the company an “overweight” rating in a research report on Thursday, October 2nd. Weiss Ratings restated a “sell (d)” rating on shares of Sotera Health in a research report on Wednesday, October 8th. Finally, Wall Street Zen upgraded Sotera Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 16th. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $17.20.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $15.11, for a total value of $120,880,000.00. Following the transaction, the director owned 41,215,301 shares in the company, valued at approximately $622,763,198.11. This represents a 16.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michael P. Rutz sold 126,611 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the completion of the transaction, the insider owned 450,204 shares in the company, valued at approximately $7,374,341.52. The trade was a 21.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 20,126,611 shares of company stock worth $304,273,888. Corporate insiders own 55.12% of the company’s stock.

Sotera Health Stock Down 0.9%

Shares of NASDAQ:SHC opened at $16.56 on Wednesday. The business’s 50 day simple moving average is $16.12 and its two-hundred day simple moving average is $13.47. The firm has a market cap of $4.70 billion, a P/E ratio of 207.03 and a beta of 1.82. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47. Sotera Health Company has a 52-week low of $9.53 and a 52-week high of $17.15.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.03. The business had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The company’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.19 earnings per share. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, research analysts forecast that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.